Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Harvard University · Massachusetts General Hospital · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,036
total citations
- FWCI
- 48.52
- Percentile
- 100%
- References
- 95
Citations per year
Authors
4- RKRakesh K JainCorresponding
Harvard University, Massachusetts General Hospital
- DGDan G. Duda
Harvard University, MGH Institute of Health Professions, Massachusetts General Hospital, Marion General Hospital
- JWJeffrey W. Clark
Harvard University, MGH Institute of Health Professions, Massachusetts General Hospital, Marion General Hospital
- JSJay S. Loeffler
Harvard University, MGH Institute of Health Professions, Massachusetts General Hospital, Marion General Hospital
Topics & keywords
Topics
Keywords
- Bevacizumab
- Medicine
- Oncology
- Colorectal cancer
- Metastatic breast cancer
- Internal medicine
- Lung cancer
- Breast cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.